Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing

Viruses

Bram Vrancken²  Nໝia Sequeira Trovão²  Guy Baele²  Eric van Wijngaerden¹  Anne-Mieke Vandamme²  Kristel van Laethem²  Philippe Lemey²  Johnson Mak³  Peter Walker³ 

[1] University Hospitals Leuven, 3000 Leuven, Belgium;Rega Institute for Medical Research, Clinical and Epidemiological Virology, Department of Microbiology and Immunology, KU Leuven—University of Leuven, 3000 Leuven, Belgium;;Rega Institute for Medical Research, Clinical and Epidemiological Virology, Department of Microbiology and Immunology, KU Leuven—University of Leuven, 3000 Leuven, Belgium

关键词: HIV;    full genome sequencing;    NGS;   

DOI  :  10.3390/v8010012

来源: mdpi

【 摘 要 】

Genetic analyses play a central role in infectious disease research. Massively parallelized “mechanical cloning” and sequencing technologies were quickly adopted by HIV researchers in order to broaden the understanding of the clinical importance of minor drug-resistant variants. These efforts have, however, remained largely limited to small genomic regions. The growing need to monitor multiple genome regions for drug resistance testing, as well as the obvious benefit for studying evolutionary and epidemic processes makes complete genome sequencing an important goal in viral research. In addition, a major drawback for NGS applications to RNA viruses is the need for large quantities of input DNA. Here, we use a generic overlapping amplicon-based near full-genome amplification protocol to compare low-input enzymatic fragmentation (Nextera™) with conventional mechanical shearing for Roche 454 sequencing. We find that the fragmentation method has only a modest impact on the characterization of the population composition and that for reliable results, the variation introduced at all steps of the procedure—from nucleic acid extraction to sequencing—should be taken into account, a finding that is also relevant for NGS technologies that are now more commonly used. Furthermore, by applying our protocol to deep sequence a number of pre-therapy plasma and PBMC samples, we illustrate the potential benefits of a near complete genome sequencing approach in routine genotyping.

【 授权许可】

CC BY   
© 2016 by the authors; licensee MDPI, Basel, Switzerland.